Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc.
1:15-cv-01155
Overview
Parties
Defendant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Purdue Pharma L.P. NPE (University / Research)
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 25 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 9,073,933 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2015026559 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,522,919 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2015025808 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016017529 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016017688 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016025020 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,777,011 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016017530 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016018578 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016025136 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016018579 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016026458 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,259,819 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,407,434 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9073933
Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
|
Filed: 2012-02-06
Issued: 2015-07-07
|
Expired (Term Ended)
Expires: 2026-02-11
|
|
|
US9522919
Oxycodone compositions
|
Filed: 2015-05-29
Issued: 2016-12-20
|
Active (8.5 yrs remaining)
Expires: 2035-05-29
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
31
Dispositive
14
Granted
1
Denied
1
Pending / Review
28
Motions by Category
Key Dispositive Motions & Rulings